GE HealthCare Technologies (GEHC) Stock Forecast & Price Target

$88.30 -1.25 (-1.40%)

Closing price 01/31/2025 04:00 PM Eastern

Extended Trading

$88.15 -0.15 (-0.17%)

As of 01/31/2025 07:24 PM Eastern

GE HealthCare Technologies - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 15 Analyst Ratings

Sell
1

Hold
4

Buy
10

Based on 15 Wall Street analysts who have issued ratings for GE HealthCare Technologies in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 15 analysts, 1 has given a sell rating, 4 have given a hold rating, 9 have given a buy rating, and 1 has given a strong buy rating for GEHC.

Consensus Price Target

$96.00
8.72% Upside

According to the 15 analysts' twelve-month price targets for GE HealthCare Technologies, the average price target is $96.00. The highest price target for GEHC is $110.00, while the lowest price target for GEHC is $74.00. The average price target represents a forecasted upside of 8.72% from the current price of $88.30.

Get the Latest News and Ratings for GEHC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for GE HealthCare Technologies and its competitors.

GEHC Analyst Ratings Over Time

Type	Current Forecast 2/3/24 to 2/2/25	1 Month Ago 1/4/24 to 1/3/25	3 Months Ago 11/5/23 to 11/4/24	1 Year Ago 2/3/23 to 2/3/24
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	9 Buy rating(s)	8 Buy rating(s)	8 Buy rating(s)	7 Buy rating(s)
Hold	4 Hold rating(s)	4 Hold rating(s)	5 Hold rating(s)	4 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$96.00	$95.46	$94.36	$84.55
Forecasted Upside	8.72% Upside	18.56% Upside	8.47% Upside	14.39% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

GEHC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

GEHC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

GE HealthCare Technologies Stock vs. The Competition

Type	GE HealthCare Technologies	Medical Companies	S&P 500
Consensus Rating Score	2.67	2.82	2.53
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	8.72% Upside	15,295.51% Upside	12.27% Upside
News Sentiment Rating	Positive News See Recent GEHC News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
1/8/2025	Jefferies Financial Group 2 of 5 stars		Upgrade	Hold ➝ Buy	$95.00 ➝ $103.00	+23.55%
10/31/2024	Wells Fargo & Company 3 of 5 stars		Boost Target	Overweight ➝ Overweight	$95.00 ➝ $96.00	+9.90%
10/1/2024	Evercore ISI 2 of 5 stars		Boost Target	Outperform ➝ Outperform	$98.00 ➝ $102.00	+10.82%
9/30/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$100.00 ➝ $102.00	+10.88%
9/26/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	G. Doyle Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Neutral ➝ Sell	$84.00 ➝ $74.00	-20.44%
9/18/2024	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Zimmerman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$100.00	+15.22%
9/9/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Neutral	$90.00	+5.77%
8/1/2024	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Ridley-Day Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
5/30/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Neutral	$87.00	+10.90%
5/1/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$94.00 ➝ $86.00	+10.45%
Get the Latest News and Ratings for GEHC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for GE HealthCare Technologies and its competitors with MarketBeat's FREE daily newsletter.
5/1/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$110.00 ➝ $105.00	+35.45%
4/3/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$88.00 ➝ $103.00	+14.62%
4/1/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$80.00 ➝ $110.00	+22.82%
2/15/2024	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$100.00	+20.24%
2/12/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$74.00 ➝ $86.00	+3.40%
5/15/2023	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$97.00	+29.45%
4/19/2023	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Overweight	$95.00	+13.55%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 01:02 PM ET.

Should I Buy GE HealthCare Technologies Stock? GEHC Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, January 22, 2025. Please send any questions or comments about these GE HealthCare Technologies pros and cons to contact@marketbeat.com.

GE HealthCare Technologies
Bull Case

Here are some ways that investors could benefit from investing in GE HealthCare Technologies Inc.:

The company reported earnings per share of $1.14 for the latest quarter, exceeding expectations and indicating strong financial performance.
GE HealthCare Technologies Inc. has a solid market capitalization of approximately $39.41 billion, reflecting its significant presence in the healthcare sector.
With a current stock price around $78.18, the stock is trading below its 12-month high of $94.55, suggesting potential for price appreciation.
The company has a return on equity of 25.19%, which indicates effective management and profitability relative to shareholder equity.
Institutional investors hold a substantial 82.06% of the company's stock, which often signals confidence in the company's future prospects.

GE HealthCare Technologies
Bear Case

Investors should be bearish about investing in GE HealthCare Technologies Inc. for these reasons:

The company has a relatively high debt-to-equity ratio of 1.12, which may indicate higher financial risk due to reliance on debt financing.
Recent short interest has increased by 6.6%, suggesting that some investors are betting against the stock, which could indicate bearish sentiment.
Analysts have mixed ratings, with one sell rating and several hold ratings, indicating uncertainty about the stock's future performance.
The price-to-earnings ratio of 23.70 may suggest that the stock is overvalued compared to its earnings, which could deter value-focused investors.
Revenue for the latest quarter was slightly below analysts' expectations, which may raise concerns about the company's growth trajectory.

GEHC Forecast - Frequently Asked Questions

: According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for GE HealthCare Technologies is $96.00, with a high forecast of $110.00 and a low forecast of $74.00.
: 15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GE HealthCare Technologies in the last year. There is currently 1 sell rating, 4 hold ratings, 9 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" GEHC shares.
: According to analysts, GE HealthCare Technologies's stock has a predicted upside of 8.72% based on their 12-month stock forecasts.
: Over the previous 90 days, GE HealthCare Technologies's stock had 1 upgrade by analysts.
: GE HealthCare Technologies has been rated by research analysts at Jefferies Financial Group in the past 90 days.
: Analysts like GE HealthCare Technologies less than other "medical" companies. The consensus rating score for GE HealthCare Technologies is 2.67 while the average consensus rating score for "medical" companies is 2.82. Learn more on how GEHC compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

This page (NASDAQ:GEHC) was last updated on 2/2/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

GE HealthCare Technologies (GEHC) Stock Forecast & Price Target